Clinical Trial Update: Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating atezolizumab in combination with a multi-kinase inhibitor for unresectable, locally advanced, or metastatic hepatocellular car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Locally Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING